Latest Breaking News On - Senior biotechnology research analyst - Page 1 : comparemela.com

IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted.

IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations Event

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted.

DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James Brown, President and CEO, will participate in a fireside chat hosted by Ed.

BioLineRx (BLRX) and Dare Biosciences (DARE), NanoCap Biotech Companies with Phase III Trials Completed and Enough Capital to Launch Products

Nanocap biotech companies with enough capital to launch a new product are a sweet spot for investors in the current market.